Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

This study was designed to evaluate whether subjects with amyloid beta (Aβ) pathology, detected using florbetapir positron emission tomorgraphy (PET), demonstrated greater cognitive decline than subjects without Aβ pathology. Sixty-nine cognitively normal (CN) controls, 52 with recently diagnosed mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Doraiswamy, P M, Sperling, R A, Johnson, K, Reiman, E M, Wong, T Z, Sabbagh, M N, Sadowsky, C H, Fleisher, A S, Carpenter, A, Joshi, A D, Lu, M, Grundman, M, Mintun, M A, Skovronsky, D M, Pontecorvo, M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195975/
https://www.ncbi.nlm.nih.gov/pubmed/24614494
http://dx.doi.org/10.1038/mp.2014.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195975/
https://www.ncbi.nlm.nih.gov/pubmed/24614494
http://dx.doi.org/10.1038/mp.2014.9

Ejemplares similares